319 related articles for article (PubMed ID: 28222600)
1. Immunoassay for Detection of Infliximab in Whole Blood Using a Fiber-Optic Surface Plasmon Resonance Biosensor.
Lu J; Spasic D; Delport F; Van Stappen T; Detrez I; Daems D; Vermeire S; Gils A; Lammertyn J
Anal Chem; 2017 Mar; 89(6):3664-3671. PubMed ID: 28222600
[TBL] [Abstract][Full Text] [Related]
2. Fiber optic-SPR platform for fast and sensitive infliximab detection in serum of inflammatory bowel disease patients.
Lu J; Van Stappen T; Spasic D; Delport F; Vermeire S; Gils A; Lammertyn J
Biosens Bioelectron; 2016 May; 79():173-9. PubMed ID: 26706938
[TBL] [Abstract][Full Text] [Related]
3. Point-of-care therapeutic drug monitoring of adalimumab by integrating a FO-SPR biosensor in a self-powered microfluidic cartridge.
Qu JH; Ordutowski H; Van Tricht C; Verbruggen R; Barcenas Gallardo A; Bulcaen M; Ciwinska M; Gutierrez Cisneros C; Devriese C; Guluzade S; Janssens X; Kornblum S; Lu Y; Marolt N; Nanjappan C; Rutten E; Vanhauwaert E; Geukens N; Thomas D; Dal Dosso F; Safdar S; Spasic D; Lammertyn J
Biosens Bioelectron; 2022 Jun; 206():114125. PubMed ID: 35255315
[TBL] [Abstract][Full Text] [Related]
4. Co(III)-NTA Mediated Antigen Immobilization on a Fiber Optic-SPR Biosensor for Detection of Autoantibodies in Autoimmune Diseases: Application in Immune-Mediated Thrombotic Thrombocytopenic Purpura.
Horta S; Qu JH; Dekimpe C; Bonnez Q; Vandenbulcke A; Tellier E; Kaplanski G; Delport F; Geukens N; Lammertyn J; Vanhoorelbeke K
Anal Chem; 2020 Oct; 92(20):13880-13887. PubMed ID: 32929962
[TBL] [Abstract][Full Text] [Related]
5. Generation of a Highly Specific Monoclonal Anti-Infliximab Antibody for Harmonization of TNF-Coated Infliximab Assays.
Van Stappen T; Brouwers E; Tops S; Geukens N; Vermeire S; Declerck PJ; Gils A
Ther Drug Monit; 2015 Aug; 37(4):479-85. PubMed ID: 25525757
[TBL] [Abstract][Full Text] [Related]
6. Determination of Serum Infliximab Concentration by Point-of-care Devices in Children With Inflammatory Bowel Disease.
Curci D; Lucafò M; Cifù A; Bramuzzo M; Martelossi S; Favretto D; De Pellegrin F; Fabris M; Vascotto F; Naviglio S; Ventura A; Stocco G; Decorti G
J Pediatr Gastroenterol Nutr; 2019 Oct; 69(4):474-479. PubMed ID: 31149938
[TBL] [Abstract][Full Text] [Related]
7. Analytical and clinical performance evaluation of two POC tests for therapeutic drug monitoring of infliximab.
Van den Bossche D; De Smet D; Debrabandere J; Vanpoucke H
Clin Chem Lab Med; 2019 May; 57(6):856-863. PubMed ID: 30838834
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the Quantum Blue® reader Point-of-Care system versus ELISA technique for therapeutic drug monitoring of Infliximab levels.
Novakovic V; Abdija S; Larsen PB; Fenger M; Gredal L; Jacobsen KK
Clin Biochem; 2019 Dec; 74():73-75. PubMed ID: 31669514
[TBL] [Abstract][Full Text] [Related]
9. Proactive therapeutic drug monitoring of infliximab: a comparative study of a new point-of-care quantitative test with two established ELISA assays.
Afonso J; Lopes S; Gonçalves R; Caldeira P; Lago P; Tavares de Sousa H; Ramos J; Gonçalves AR; Ministro P; Rosa I; Vieira AI; Dias CC; Magro F;
Aliment Pharmacol Ther; 2016 Oct; 44(7):684-92. PubMed ID: 27507790
[TBL] [Abstract][Full Text] [Related]
10. Surface plasmon resonance assays for the therapeutic drug monitoring of infliximab indicate clinical relevance of anti-infliximab antibody binding properties.
Grasmeier MK; Weber S; Treiber M; Thaler MA; Luppa PB
Clin Chem Lab Med; 2023 Jun; 61(7):1255-1265. PubMed ID: 36753693
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of an optical biosensor for rapid monitoring of adalimumab in serum of patients with Crohn's disease.
Bian S; Lu J; Delport F; Vermeire S; Spasic D; Lammertyn J; Gils A
Drug Test Anal; 2018 Mar; 10(3):592-596. PubMed ID: 28743169
[TBL] [Abstract][Full Text] [Related]
12. Comparisons of Serum Infliximab and Antibodies-to-Infliximab Tests Used in Inflammatory Bowel Disease Clinical Trials of Remicade®.
Marini JC; Sendecki J; Cornillie F; Popp JW; Black S; Blank M; Gils A; Van Stappen T; Hamann D; Rispens T; Thérien L; Chun K; Shankar G
AAPS J; 2017 Jan; 19(1):161-171. PubMed ID: 27600137
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Point-of-Care and Classical Immunoassays for the Monitoring Infliximab and Antibodies Against Infliximab in IBD.
Nasser Y; Labetoulle R; Harzallah I; Berger AE; Roblin X; Paul S
Dig Dis Sci; 2018 Oct; 63(10):2714-2721. PubMed ID: 29948562
[TBL] [Abstract][Full Text] [Related]
14. FO-SPR biosensor calibrated with recombinant extracellular vesicles enables specific and sensitive detection directly in complex matrices.
Yildizhan Y; Vajrala VS; Geeurickx E; Declerck C; Duskunovic N; De Sutter D; Noppen S; Delport F; Schols D; Swinnen JV; Eyckerman S; Hendrix A; Lammertyn J; Spasic D
J Extracell Vesicles; 2021 Feb; 10(4):e12059. PubMed ID: 33664936
[TBL] [Abstract][Full Text] [Related]
15. An Optimized Anti-infliximab Bridging Enzyme-linked Immunosorbent Assay for Harmonization of Anti-infliximab Antibody Titers in Patients with Inflammatory Bowel Diseases.
Van Stappen T; Billiet T; Vande Casteele N; Compernolle G; Brouwers E; Vermeire S; Gils A
Inflamm Bowel Dis; 2015 Sep; 21(9):2172-7. PubMed ID: 26284296
[TBL] [Abstract][Full Text] [Related]
16. Surface plasmon resonance unveils important pitfalls of enzyme-linked immunoassay for the detection of anti-infliximab antibodies in patients' sera.
Beeg M; Burti C; Allocati E; Ciafardini C; Banzi R; Nobili A; Caprioli F; Garattini S; Gobbi M
Sci Rep; 2021 Jul; 11(1):14976. PubMed ID: 34294782
[TBL] [Abstract][Full Text] [Related]
17. Infliximab trough levels: A comparison between the Quantum Blue Infliximab assay and the established ELISA.
Lim MH; Aluzaite K; Schultz M; Casey P
J Gastroenterol Hepatol; 2020 Aug; 35(8):1302-1306. PubMed ID: 31881552
[TBL] [Abstract][Full Text] [Related]
18. Dried blood samples can support monitoring of infliximab concentrations in patients with inflammatory bowel disease: A clinical validation.
Berends SE; D'Haens GRAM; Schaap T; de Vries A; Rispens T; Bloem K; Mathôt RAA
Br J Clin Pharmacol; 2019 Jul; 85(7):1544-1551. PubMed ID: 30927375
[TBL] [Abstract][Full Text] [Related]
19. Real-time ligation chain reaction for DNA quantification and identification on the FO-SPR.
Knez K; Spasic D; Delport F; Lammertyn J
Biosens Bioelectron; 2015 May; 67():394-9. PubMed ID: 25212376
[TBL] [Abstract][Full Text] [Related]
20. Performance of a New Rapid Point-of-Care Test for Infliximab Levels in Patients with Inflammatory Bowel Disease: A Comparison to ELISA.
Valdés-Delgado T; Aguado-Paredes A; Merino-Bohórquez V; Martín-Manzanares J; Alonso MM; Maldonado B; Castro L; Belvis M; Benítez B; Caunedo Á; Calleja MÁ; Argüelles-Arias F
Dig Dis Sci; 2024 Jan; 69(1):228-234. PubMed ID: 37943382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
